DLHC DLHC
Company Profile ↓Company Overview
DLHC (DLHC) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 23.8% CAGR over the past five years.
Recent Developments
- Sep 2025 Revenue of $344.50M (-13.0% YoY).
- Trailing 12 Months Year-on-year growth — revenue -13.0%, earnings -44.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 23.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 23.76% |
| 1 Year: | -12.99% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -44.16% |
Stock Price Performance
| 1 Year: | -13.42% |
| 6 Months: | -17.41% |
| 3 Months: | -14.34% |
| 1 Month: | -7.81% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)38.44 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 23.8% over 5 years.
CONS
- Trading at a high P/E of 53.8.
- Trading 26.3% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Profit | 5.46M | 6.23M | 5.81M | 6.40M | 6.38M | 7.25M | 6.53M | 7.45M | 8.34M | 7.88M | 7.79M | 8.07M | 9.92M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 1.67M | 1.32M | 889.00K | 1.84M | 1.75M | 2.15M | 1.15M | 2.20M | 2.61M | 2.82M | 2.56M | 2.33M | 1.69M | 3.39M | 3.13M | 3.84M | 3.80M | 2.70M | 3.63M | 4.62M | 4.94M | 4.03M | 11.22M | 10.25M | 7.11M | 4.69M | 3.92M | 5.95M | 7.11M | 6.82M | 5.94M | 5.76M | 6.38M | 5.64M | 5.12M | 3.75M | 2.28M | 1.44M | -55.00K | -3.93M |
| Diluted EPS | 0.07 | 0.20 | 0.03 | 0.08 | 0.08 | 0.08 | -0.24 | 0.10 | 0.13 | 0.14 | 0.13 | 0.10 | 0.06 | 0.12 | 0.12 | 0.16 | 0.16 | 0.10 | 0.13 | 0.19 | 0.21 | 0.21 | 0.55 | 0.50 | 0.34 | 0.24 | 0.11 | 0.06 | 0.12 | 0.15 | 0.12 | 0.08 | 0.16 | 0.08 | 0.06 | 0.02 | -0.06 | -0.09 | -0.17 | -1.16 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 40.87M | 41.92M | - | - | - | - | - | 115.66M | 133.24M | 160.39M | 209.19M | 246.09M | 395.17M | 375.87M | 395.94M | 344.50M |
| Gross Profit | 4.81M | 5.90M | 5.60M | 7.50M | 8.96M | 11.69M | 17.83M | 25.85M | 30.20M | - | - | - | - | - | - | - |
| Operating Income | -4.34M | -4.22M | -2.15M | 248.00K | 764.00K | 2.50M | 4.06M | 6.63M | 8.78M | 9.97M | 13.46M | 17.22M | 33.28M | 17.09M | 24.90M | 16.79M |
| Net Income | -5.81M | -4.32M | -2.03M | -159.00K | 5.36M | 8.73M | 3.38M | 3.29M | 1.84M | - | - | - | - | - | - | - |
| Diluted EPS | - | - | - | -0.02 | 0.54 | 0.87 | 0.30 | 0.27 | 0.14 | 0.41 | 0.54 | 0.75 | 1.64 | 0.10 | 0.51 | 0.09 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2009 | Sep 2010 | Sep 2011 | Jun 2012 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 25.24M | 21.92M | - | 26.42M | 25.76M | 30.07M | 28.62M | 65.07M | 69.72M | 62.54M | 129.26M | 183.56M | 197.17M | 169.01M | 339.84M | 314.38M | 290.66M |
| Total Equity | 13.82M | 8.39M | 5.55M | - | 7.75M | 7.78M | 13.85M | 22.87M | 31.78M | 35.85M | 39.42M | 45.57M | 53.44M | 65.61M | 92.06M | 102.44M | 110.13M | 112.96M |
| Cash & Equivalents | 2.99M | 1.19M | 763.00K | 3.13M | 3.09M | 3.41M | 3.91M | 5.56M | 3.43M | 4.93M | 6.36M | 1.79M | 1.36M | 24.05M | 228.00K | 215.00K | 342.00K | 125.00K |
| Long Term Debt | - | - | - | - | - | - | 0 | 0 | 23.44M | 19.69M | 7.71M | 53.63M | 60.54M | 44.64M | 20.42M | 155.15M | 137.32M | 119.97M |
| Total Liabilities | - | 16.85M | 16.36M | - | 18.67M | 17.97M | 16.23M | 5.75M | 33.30M | 33.87M | 23.12M | 83.69M | 130.12M | 131.56M | 76.95M | 237.40M | 204.25M | 177.71M |
| Current Liabilities | - | 16.84M | 16.13M | - | 18.27M | 17.95M | 16.21M | 5.65M | 14.52M | 21.44M | 15.93M | 29.48M | 47.96M | 66.38M | 38.54M | 64.79M | 53.24M | 42.67M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.24M | -987.00K | -2.83M | 1.80M | 1.67M | 1.98M | 6.04M | 6.52M | 14.08M | 18.04M | 19.45M | 45.66M | 1.24M | 31.03M | 27.37M | 23.22M |
| Investing Cash Flow | 181.00K | -37.00K | -68.00K | -9.00K | -13.00K | -142.00K | -32.74M | -1.31M | -654.00K | -67.48M | -32.83M | -44.00K | -872.00K | -181.20M | -836.00K | -241.00K |
| Financing Cash Flow | 258.00K | 600.00K | 5.23M | -1.48M | -1.15M | -191.00K | 24.57M | -3.71M | -12.00M | 44.88M | 12.95M | -22.93M | -24.19M | 150.15M | -26.40M | -23.19M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | 0 | 211.00K | 0 | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Sep 2010 | Sep 2011 | Sep 2012 | Sep 2013 | Sep 2014 | Sep 2015 | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 11.8% | 14.1% | - | - | - | - | - | 22.3% | 22.7% | - | - | - | - | - | - | - |
| Operating Margin % | -10.6% | -10.1% | - | - | - | - | - | 5.7% | 6.6% | 6.2% | 6.4% | 7.0% | 8.4% | 4.5% | 6.3% | 4.9% |
| Net Margin % | -14.2% | -10.3% | - | - | - | - | - | 2.8% | 1.4% | - | - | - | - | - | - | - |
| ROE % | -69.2% | -77.8% | -26.1% | -2.0% | 38.7% | 38.2% | 10.6% | 9.2% | 4.7% | - | - | - | - | - | - | - |
| ROCE % | -51.6% | -73.0% | -26.4% | 3.2% | 5.5% | 10.9% | 8.0% | 13.7% | 18.8% | 10.0% | 9.9% | 13.2% | 25.5% | 6.2% | 9.5% | 6.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DLHC
DLH Holdings Corp (DLHC) (Q3 2026) Earnings Call Highlights: Revenue Decline Amid Strategic ...
DLH Holdings Corp (DLHC) navigates a transitional quarter with a new IDIQ contract and improved procurement clarity, while focusing on margin recovery and debt reduction.
DLH Q3 Earnings Call Highlights
DLH (NASDAQ:DLHC) reported fiscal 2026 third-quarter revenue of $44.2 million as the company completed the transition of its Veterans Affairs Consolidated Mail Outpatient Pharmacy, or CMOP, program to small-business set-aside contractors an…
DLH Holdings Corp. (DLHC) Reports Q3 Loss, Lags Revenue Estimates
DLH (DLHC) delivered earnings and revenue surprises of -158.82% and -11.55%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
DLH Reports Fiscal 2026 Third Quarter Results
ATLANTA, July 29, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science research and development…
DLH to Announce Fiscal 2026 Third Quarter Financial Results
ATLANTA, July 20, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber securit…
DLH Announces Leadership Transition
Zach Parker to Retire; Kathryn JohnBull Appointed CEO; Steve Oroho Appointed CFOATLANTA, June 30, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersec…
DLHC — Frequently Asked Questions
What is the current share price of DLHC?
As of 2026-08-05 17:25 PDT, DLHC trades at $4.84 on NASDAQ/NYSE. Its 52-week range is $4.84 to $6.57.
What is the P/E ratio of DLHC?
DLHC trades at a trailing price-to-earnings (P/E) ratio of 53.78.
What is the return on equity (ROE) of DLHC?
DLHC has a return on equity (ROE) of 1.63%. Its return on capital employed (ROCE) is 6.77%.
Is DLHC a good stock to buy?
This page provides a data-driven analysis of DLHC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.